Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs in the United States. The company develops RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; and RAD204, a Nano-mAb PDL1 non-small cell lung therapeutic. It is also developing RAD301 and RAD302, which are Avß6-Integrin pancreatic diagnostic and therapeutic products; RAD401, a PSA-mAb prostate cancer diagnostic; and RAD402, a PSA-mAb prostate cancer therapeutic. The company was incorporated in 2021 and is based in Carlton, Australia.
Frequently asked questions
What sector does Radiopharm Theranostics Limited American Depositary Shares (RADX) operate in?
Radiopharm Theranostics Limited American Depositary Shares belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Radiopharm Theranostics Limited American Depositary Shares (RADX) current stock price?
As of the latest data, Radiopharm Theranostics Limited American Depositary Shares stock price is $0.94, with a previous close of $1.00. Radiopharm Theranostics Limited American Depositary Shares lost -$0.06 in the last trading session, representing a -5.62% loss.
What is Radiopharm Theranostics Limited American Depositary Shares (RADX) current market capitalization?
Radiopharm Theranostics Limited American Depositary Shares market cap is approximately 13.72 million.
What is Radiopharm Theranostics Limited American Depositary Shares (RADX) Earnings Per Share (EPS)?
The trailing EPS is -$3.64, and the forward EPS is -$3.23.
What is Radiopharm Theranostics Limited American Depositary Shares (RADX) EBITDA?
Radiopharm Theranostics Limited American Depositary Shares EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -39.91 million.
Does Radiopharm Theranostics Limited American Depositary Shares (RADX) pay dividends?
No. Radiopharm Theranostics Limited American Depositary Shares does not pay a dividend.
What is Radiopharm Theranostics Limited American Depositary Shares (RADX) beta (volatility) score?
Radiopharm Theranostics Limited American Depositary Shares has a beta of 0.860, meaning its volatility is roughly in line with the market.
